Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection

Sponsor
Kasr El Aini Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03420573
Collaborator
(none)
300
24

Study Details

Study Description

Brief Summary

There is association between Hepatitis C and Parkinson's Disease as shown from previous studies. The clinical profile and natural history is not fully studied yet. We aim at studying the clinical characteristics of Parkinson's Disease in patients with hepatitis C infection.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection
    Anticipated Study Start Date :
    Mar 1, 2018
    Anticipated Primary Completion Date :
    Oct 1, 2019
    Anticipated Study Completion Date :
    Mar 1, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Score of UPDRS [2 years]

      Severity of Motor and non motor symptoms

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient with history of Parkinson's Disease and Hepatitis C infection.
    Exclusion Criteria:
    • Advanced liver cirrhosis.

    • Patients with hepatic failure.

    • Symptoms of Parkinson's plus syndrome.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Kasr El Aini Hospital

    Investigators

    • Study Director: Shaimaa I. El-Jaafary, MD, Director of Kasr Alainy Movement Disorders Unit KAMDU

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Shaimaa El-Jaafary, Lecturer of Neurology, Kasr El Aini Hospital
    ClinicalTrials.gov Identifier:
    NCT03420573
    Other Study ID Numbers:
    • KAMDUPDHC
    First Posted:
    Feb 5, 2018
    Last Update Posted:
    Feb 5, 2018
    Last Verified:
    Jan 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 5, 2018